CWRU School of Medicine students pursuing a MD/PhD in Genetics study in the Medical Scientist Training Program (MSTP). The MD/PhD combined degree program generally takes approximately 7 to 8 years to ...

MajesTEC-3 trial should encourage the use of teclistamab. Luciano Costa, MD, PhD, discusses the how the MajesTEC-3 trial's 83% improvement in PFS contributed to a 3-month turnaround to FDA approval.

Cooper Medical School of Rowan University (CMSRU) has launched the PhD in Cancer Cell Biology & Genomics (CCBG), a new ...

Can you tell me a little bit about yourself before you came to the College of Medicine? Before coming to Drexel, I completed my undergraduate studies at Stony Brook University, where I majored in ...

In case you have decided to apply for Md/PhD program, because you are fascinated by research discoveries as well as clinical work, but you feel intimidated thinking these programs are too competitive, ...

Building on her discovery of the GLP-1 signaling pathway's role in sarcoma biology, Erica Pimenta, MD, PhD, of the Dana-Farber Cancer Institute, is exploring the therapeutic poten ...

Ben Shofty, MD/PhD is an Israeli-board certified functional neurosurgeon and a former Israeli national rugby player. He graduated from the Tel-Aviv University Faculty of Medicine, and received a PhD ...

Appointment of Rimidi founder Dr. Lucienne Ide as CMO strengthens HRS’s clinical leadership and advances their vision ...

Dr. Jim Boonyaratanakornkit is an infectious disease specialist and virologist whose research and clinical practice focus on preventing and treating viral infections in the respiratory system, blood, ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed a decreased percentage of applicants reporting household income less than $50,000. The ...

Angelo P. Giardino, MD, PhD, MPH, is the Wilma T. Gibson Presidential Professor and Chair of the Department of Pediatrics at the University of Utah’s School of Medicine and Chief Medical Officer at ...